Tatva Chintan Pharma Chem Ltd Q2FY24; 9% rise in Profits

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals

Financial Results:

Tatva Chintan Pharma Chem Ltd reported Revenues for Q2FY24 of ₹96.67 Crores up from ₹90.09 Crore year on year, a rise of 7.3%.

Total Expenses for Q2FY24 of ₹86.22 Crores up from ₹82.58 Crores year on year, a rise of 4.41%.

Consolidated Net Profit of ₹7.78 Crores up 9.42% from ₹7.11 Crores in the same quarter of the previous year.

The Earnings per Share is ₹3.33, up 3.74% from ₹3.21 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.